New York, According to a new market research report published by Global Insight Services “Hepatitis D (HDV) Market” is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Hepatitis D, also known as delta hepatitis, is an inflammation of the liver caused by the hepatitis D virus (HDV), which requires HBV for its replication. Hepatitis D infection cannot occur in the absence of hepatitis B virus. HDV-HBV co-infection is considered the most severe form of chronic viral hepatitis due to more rapid progression towards hepatocellular carcinoma and liver-related death.
Download a Free PDF Sample Copy of Report : https://www.globalinsightservices.com/request-sample/GIS31055
The primary route of transmission for hepatitis D is contact with infected blood or other bodily fluids. This can happen through sharing needles or drug materials with an infected person or having unprotected sex with an infected person. The signs and symptoms of HDV can include: yellow skin and eyes (jaundice), stomach upset, pain in your belly, throwing up, fatigue, loss of appetite, joint pain, dark urine, light-colored stool.
Diagnosis includes bloodwork and imaging tests to check liver for signs of damage. To make an accurate diagnosis, doctor will perform a blood test that can detect anti-hepatitis D antibodies in the blood. There may be additional tests to determine if there is liver damage as a result of hepatitis D. The tests can include: An elastography and A liver biopsy.
Medications are not effective against acute hepatitis D; the acute infection tends to subside on its own. As for chronic hepatitis D, appropriate treatment depends on the phase of the disease and how severe the infection is. If a person’s liver is severely damaged, a liver transplant may become necessary. Doctors may prescribe a drug called interferon alfa or, alternatively, one called pegylated interferon alpha, for chronic hepatitis D.
The companies that are active in the development of HDV drugs. Some of them include, Antios Therapeutics, Inc, Eiger BioPharmaceuticals, Gilead Sciences, Inc., Hepatera Ltd, Merck & Co., Inc etc.
Report Highlights
Global Insight Service’s, Hepatitis D (HDV) – Drug Pipeline Landscape, 2022 report provides an overview of the Hepatitis D pipeline drugs. This report covers detailed insights on Hepatitis D (HDV) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Hepatitis D (HDV) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Key Players
- Antios Therapeutics, Inc
- Eiger BioPharmaceuticals Inc
- Gilead Sciences Inc
- Hepatera Ltd.
- Janssen Research & Development, LLC
- PharmaEssentia
- Replicor Inc.
- Vir Biotechnology, Inc.
- VLP Biotech
Get Customized report as per your requirements : https://www.globalinsightservices.com/request-customization/GIS31055
Reasons to buy Hepatitis D (HDV) Market Report:
• Develop comprehensive understanding of market landscape – industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/